Ramila Remedies Pvt Ltd is a pharmaceutical research and development company specializing in innovative therapeutic approaches. Our focus areas include molecular targeted therapeutics, regenerative medicine, repurposing of known compounds, and theranostics. We aim to develop novel therapies that target specific disease mechanisms, promote tissue regeneration, and optimize patient outcomes. Our mission is to lead the way in pioneering innovative treatments that make a meaningful difference in the lives of patients worldwide.
Our Background
Ongoing Research
Our Projects
Theragnostic or Theranostics Concept: Integrating diagnostic and therapeutic elements within a single platform for personalized treatment approaches, revolutionizing patient care through tailored interventions.
Upcoming Projects
Stay tuned for our upcoming projects that will focus on addressing the unmet needs of patients suffering from severe conditions. We are committed to improving patient outcomes.
Completed Projects
Over the years, we have successfully completed several projects in the areas of cancer and immune-related diseases. Our expertise and dedication have resulted in effective drugs for patients in need.
Our team of researchers and scientists are continuously conducting research to discover and develop novel products for severe conditions. We are focused on making a difference in patient care.
We are currently working on groundbreaking projects in the fields of cancer, infectious diseases, and inflammation. Our aim is to develop innovative treatments that will revolutionize patient care.
Regenerative and miRNA, Mitochondrial, and Compensating Approach: Innovative strategies harnessing regenerative properties, miRNA modulation, mitochondrial function enhancement, and compensatory mechanisms for advanced therapeutic interventions.
Molecular Targeted Therapeutics: Precision medicines tailored to specific molecular targets for enhanced treatment efficacy.
Repurposing of Known and Established AIPs/Drugs/Alkaloids/Molecules: Leveraging existing compounds through repurposing for novel therapeutic applications, optimizing resources for accelerated drug development.
